|
|
||||||||
Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226
| |
ABSTRACT |
|---|
|
|
|---|
We recently reported that an enzyme of
the cytochrome P-450 4A family is
expressed in the glomerulus, but there is no evidence that
20-hydroxyeicosatetraenoic acid (20-HETE) can be produced by this
tissue. The purpose of present study was to determine whether glomeruli
isolated from the kidney of rats can produce 20-HETE and whether the
production of this metabolite is regulated by nitric oxide (NO) and
dietary salt intake. Isolated glomeruli produced 20-HETE,
dihydroxyeicosatrienoic acids, and 12-hydroxyeicosatetraenoic acid
(4.13 ± 0.38, 4.20 ± 0.38, and 2.10 ± 0.20 pmol · min
1 · mg
protein
1, respectively)
when incubated with arachidonic acid (10 µM). The formation of
20-HETE was dependent on the availability of NADPH and the
PO2 of the incubation medium. The
formation of 20-HETE was inhibited by NO donors in a
concentration-dependent manner. The production of 20-HETE was greater
in glomeruli isolated from the kidneys of rats fed a low-salt diet than
in kidneys of rats fed a high-salt diet (5.67 ± 0.32 vs. 2.83 ± 0.32 pmol · min
1 · mg
protein
1). Immunoblot
experiments indicated that the expression of
P-450 4A protein in glomeruli from the
kidneys of rats fed a low-salt diet was sixfold higher than in kidneys
of rats fed a high-salt diet. These results indicate that arachidonic
acid is primarily metabolized to 20-HETE and dihydroxyeicosatrienoic
acids in glomeruli and that glomerular
P-450 activity is modulated by NO and
dietary salt intake.
renal hemodynamics; eicosanoids; 20-hydroxyeicosatetraenoic acid; nitric oxide; hypertension; renal disease; 12-hydroxyeicosatetraenoic acid; epoxyeicosatrienoic acids; cytochrome P-450
| |
INTRODUCTION |
|---|
|
|
|---|
RECENT STUDIES have indicated that
20-hydroxyeicosatetraenoic acid (20-HETE) is the primary metabolite of
arachidonic acid (AA) produced by the kidney (10, 24, 29, 32, 38) and that this substance plays a critical role in the regulation of renal
tubular and vascular function. 20-HETE is a potent constrictor of renal
arterioles (19, 23). Inhibition of the formation of 20-HETE blocks
autoregulation of renal blood flow and tubuloglomerular feedback
responses in the rat in vivo (47, 48). 20-HETE is also produced in the
proximal tubule (29) and the thick ascending limb of the loop of Henle
(TALH) (10), where it inhibits
Na+-K+-ATPase
(30) and serves as a second messenger regulating loop Cl
transport (11, 44).
Recent studies have also suggested an important role for 20-HETE in the
long-term control of arterial pressure (29, 31, 36-38). In this
regard, the P-450 4A locus on
chromosome 5 cosegregates with blood pressure in an
F2 population derived from Dahl S,
spontaneously hypertensive, and normotensive strains of rats (36, 38).
The formation of 20-HETE is catalyzed by enzymes of the cytochrome
P-450 4A family (28). Over 13 isoforms
have been reported in various species (28, 43). Four isoforms
(P-450 4A1, 4A2, 4A3, and 4A8) are
expressed in the kidney of rats (20).
P-450 4A1, 4A2, and 4A3 catalyze the
-hydroxylation of fatty acids and produce 20-HETE when incubated
with AA (43). We recently demonstrated that
P-450 4A mRNA and protein are avidly
expressed in the proximal tubule, TALH, and renal microvessels of the
rat (20). These observations are consistent with the results of previous studies indicating that all these structures produce 20-HETE
when incubated with AA (10, 19, 29, 47). Glomeruli also express mRNA
and protein for P-450 4A enzymes (20).
However, there is no evidence that the glomerulus can produce 20-HETE. Rather, all previous studies indicated that isolated glomeruli produce
cyclooxygenase (17) and lipoxygenase (5, 35) metabolites when incubated
with AA.
Why P-450 4A protein is expressed in glomeruli but is inactive is unknown. One possibility might be that the formation of 20-HETE in glomeruli is modulated by the endogenous formation of nitric oxide (NO). This hypothesis is based on the recent findings that NO inhibits the formation of 20-HETE in the kidney and that this contributes to the vasodilator effects of NO in the renal microcirculation (1, 40). Thus the purpose of the present study was to determine whether glomeruli isolated from the kidney of rats can produce 20-HETE and to examine the effects of NO and dietary salt intake on the metabolism of AA in the glomerulus. Our results indicate that AA is primarily metabolized via the cytochrome P-450 pathway to 20-HETE and dihydroxyeicosatrienoic acids (diHETEs) in isolated glomeruli and that the formation of these products requires exogenous NADPH and is modulated by PO2, NO, and dietary salt intake.
| |
METHODS |
|---|
|
|
|---|
Animals. Experiments were performed on male, 9-wk-old Lewis rats (Lew/CrlBR) purchased from Charles River Laboratories (Wilmington, MA). The rats were housed in an animal care facility at the Medical College of Wisconsin that is approved by the American Association for Accreditation of Laboratory Animal Care. Most of the rats (n = 40) were maintained on a normal-salt diet (1% NaCl by weight) and had free access to food and water throughout the study. Some rats were fed a high-salt (8% NaCl by weight, n = 8) or a low-salt (0.4% NaCl by weight, n = 8) diet for 2 wk before the study. All protocols involving animals were reviewed and received prior approval by the Animal Welfare Committee at the Medical College of Wisconsin.
Isolation of glomeruli.
Glomeruli were isolated by using a rapid-sieving technique originally
described by Spiro (34). The rats were anesthetized with pentobarbital
sodium (50 mg/kg ip), and the abdominal aorta was cannulated with a
PE-50 catheter below the left renal artery. Blood flow to the kidneys
was interrupted, and the kidneys were flushed with 10 ml of cold
dissection solution (4°C) containing (in mM) 135 NaCl, 3 KCl, 1.5 CaCl2, 1 MgCl2, 2 KH2PO4,
5.5 glucose, and 10 HEPES (pH 7.4). The kidneys were rapidly removed
and hemisected, and the medulla was excised. Pieces of the renal cortex
were forced through a 180-µm stainless steel sieve with use of the
barrel of a 30-ml syringe. The material passing through the sieve was flushed through a 100-µm sieve and collected on a 70-µm nylon sieve. The retained tissue was then washed off this sieve and divided
into two portions. One-half of the glomeruli were used for the study of
AA metabolism. The remainder of the sample was resuspended in 200 µl
of cold homogenization buffer containing 100 mM potassium phosphate (pH
7.25), 30% glycerol, 1 mM dithiothreitol, and 0.1 mM
phenylmethylsulfonyl fluoride and homogenized by sonication for 15 s at
moderate power. Aliquots of this homogenate were used in immunoblot
experiments. The protein concentration of the homogenates was measured
using the Bradford method (7) with bovine
-globulin (Bio-Rad
Laboratories, Hercules, CA) as a standard.
-glutamyltransferase protein, which is a specific maker for proximal
tubules (15), in glomerular and proximal tubular samples by using
immunoblot analysis.
Metabolism of AA in isolated glomeruli. Isolated glomeruli were preincubated with 0.1% Tween 80 in a 100 mM potassium phosphate buffer (pH 7.4) containing 10 mM MgCl2 and 1 mM EDTA for 15 min at 4°C to permeabilize the tissue and ensure free access of exogenous AA and NADPH to the P-450 enzymes located in the endoplasmic reticulum. The glomeruli (1 mg protein) were washed twice, spun down, and incubated with [14C]AA (0.1 µCi/ml, 10 µM; Amersham Life Science, Arlington Heights, IL) in 1 ml of the potassium phosphate buffer containing 1 mM NADPH and an NADPH-regenerating system (10 mM isocitrate and 0.4 U/ml isocitrate dehydrogenase) in a shaking water bath for 60 min at 37°C. This incubation time was based on preliminary experiments indicating that the formation of diHETEs and 20-HETE was linear for up to 75 min. We previously reported that the metabolism of AA by P-450 4A enzymes in renal tissue is O2 dependent with a Michaelis-Menten constant of ~50 Torr (16). Therefore, 100% O2 gas was blown over the surface of the incubations to maintain the PO2 in the medium at a normal physiological level for the renal cortex of a rat (~100 Torr). The reactions were terminated by acidification to pH 4.0 with 0.1 M formic acid, and the glomeruli were homogenized in the incubation medium by sonication for 60 s at moderate power. AA metabolites were extracted twice from this homogenate with 3 ml of ethyl acetate and dried under N2 gas. The metabolites were resuspended in 500 µl of 100% ethanol and separated using an HPLC gradient system (model 655A-1, Hitachi, Tokyo, Japan) equipped with a 2.1 × 250-mm C18 reverse-phase column and a linear elution gradient ranging from acetonitrile-water-acetic acid (50:50:2 vol/vol/vol) to acetonitrile-acetic acid (100:0.2 vol/vol) over a 40-min period. Products were monitored using a radioactive flow detector (model A-120, Radiomatic Instrument, Tampa, FL). The production rate for each metabolite was calculated and expressed as picomoles formed per minute per milligram of protein.
Immunoblot analysis of P-450 4A protein. Proteins were separated by electrophoresis on a 10 × 20-cm, 8.5% SDS polyacrylamide gel for 1.5 h at 150 V. The proteins were transferred to a nitrocellulose membrane at 100 V in a transfer buffer consisting of 25 mM Tris · HCl, 192 mM glycine, and 20% methanol for 1 h at 4°C. The membrane was blocked overnight at 4°C by immersion into a buffer (TBST-20) containing 10 mM Tris · HCl, 150 mM NaCl, 0.08% Tween 20, and 10% nonfat dry milk (Bio-Rad). The membrane was incubated for 2 h with a 1:2,000 dilution of a goat polyclonal antibody raised against rat P-450 4A1 that recognizes other P-450 4A isoforms (20) (Daiichi Pure Chemicals, Tokyo, Japan). The membrane was rinsed several times with TBST-20 buffer and then incubated with a 1:4,000 dilution of a horseradish peroxidase-coupled, anti-goat secondary antibody (Santa Cruz Biolaboratory, Santa Cruz, CA) for 1 h. The blots were washed three to four times for 5 min in TBST-20 developed using an enhanced chemiluminesence kit (ECL, Amersham, Arlington Heights, IL). The relative intensities of the bands in the 50- to 52-kDa range were measured with a densitometer (Personal Densitometer SI, Molecular Dynamics, Sunnyvale, CA).
Statistics. Values are means ± SE. The significance of differences in mean values was evaluated using ANOVA and Duncan's multiple range test. P < 0.05 was considered to be statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Quality of the glomeruli.
The preparations contained >98% intact glomeruli, and vascular poles
were present on <1% of the glomeruli. Alkaline phosphatase activities of the proximal tubular preparations were 20-fold higher than those measured in sieved glomeruli. There was no significant difference in the alkaline phosphatase activity between bulk-isolated and microdissected glomeruli (Table 1). The
immunoblot experiments with
-glutamyltransferase also indicated that
the levels of this protein were 60-fold greater in proximal tubules
than in isolated glomeruli (Fig. 1).
|
|
Metabolism of AA by glomeruli.
A representative reverse-phase HPLC chromatogram depicting the profile
of metabolites of AA produced by intact glomeruli isolated from an
inbred Lewis rat is presented in Fig.
2A. The
products with retention times of 6.5, 7.5, and 8 min coeluted with
synthetic 14,15-, 11,12-, and 8,9-diHETE standards, respectively. The
products with retention times of 9.5 and 13.5 min coeluted with
synthetic 20-HETE and 12-hydroxyeicosatetraenoic acid (12-HETE)
standards. The products with retention times of 16.5, 18, and 18.5 min
coeluted with synthetic 14,15-, 11,12-, and 8,9-epoxyeicosatrienoic
acid (EET) standards, respectively. The peaks with retention times of
1-5 min represent cyclooxygenase metabolites of AA and polar breakdown metabolites of the P-450
products.
|
1 · mg
protein
1, respectively.
Additional studies were performed to evaluate the effects of
pharmacological inhibitors on the production of
P-450 metabolites. Preincubation of
isolated glomeruli with 10 µM 17-octadecynoic acid, an inhibitor of
P-450 4A enzymes (49), reduced the
formation of 20-HETE and diHETEs (Fig.
3B). It
had no significant effect on the production of 12-HETE. Miconazole (10 µM), a selective inhibitor of P-450
epoxygenase (8, 49), reduced the formation of diHETEs, but it had no
significant effect on the production of 20-HETE (Fig.
3C). Preincubation of glomeruli with
a high concentration (20 µM) of indomethacin reduced the formation of
products with retention times of 1-5 min (Fig.
4B),
indicating that some of these products are cyclooxygenase metabolites.
However, this high concentration of indomethacin also reduced the
formation of 20-HETE and diHETEs by 50%. This finding is consistent
with the previous findings of Capdevila et al. (8) indicating that
>10 µM indomethacin inhibits cytochrome
P-450 enzymes. Baicalein (0.5 µM), a
selective 12-lipoxygenase inhibitor (33), reduced the formation of
12-HETE, but it had little effect on the formation of diHETEs or
20-HETE (Fig. 4C).
|
|
Effect of NO donors on glomerular P-450 activity.
The results of these experiments are summarized in Fig.
5. Addition of sodium nitroprusside (SNP,
10
3 M) to the incubation
completely blocked the production of 20-HETE and diHETEs by isolated
glomeruli, but it had no effect on the formation of polar
cyclooxygenase metabolites or 12-HETE (Fig. 5B). The inhibitory effects of SNP
on the production of 20-HETE by glomeruli were concentration dependent.
At 10
5,
10
4, and
10
3 M, SNP reduced the
formation of 20-HETE to 67.2 ± 11.2, 28.6 ± 2.1, and 0 ± 0% of control, respectively (Fig.
5C). Similar results were obtained
after the addition of the long-acting NO donor
1-propanamine,3-(2-hydroxy-2-nitroso-1-propylhydrazino (PAPA NONOate) to the incubation. At
10
5,
10
4, and
10
3 M, PAPA NONOate reduced
the production of 20-HETE to 74.2 ± 6.8, 47.2 ± 3.8, and 13.0 ± 4.1% of control, respectively (Fig.
5C).
|
Effect of dietary salt intake on glomerular P-450 activity.
The metabolism of AA was compared in glomeruli isolated from the
kidneys of Lewis rats maintained on low-salt (0.4% NaCl by weight),
normal-salt (1% NaCl by weight), or high-salt (8% NaCl by weight)
diets for 2 wk. The results of these experiments are presented in Fig.
6. The production of 20-HETE and diHETEs
was significantly greater in glomeruli of rats fed a low-salt diet than
in those fed a normal- or a high-salt diet. In contrast, production of
12-HETE was about twofold greater in glomeruli isolated from rats fed a
high-salt diet than in those fed a low-salt diet.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Recent studies have indicated that mRNA and protein for P-450 4A enzymes are expressed in the proximal tubule (20, 29), TALH (10, 20), and renal microvessels (19, 20, 23, 47). All these tissues produce 20-HETE when incubated with AA. Despite the fact that the cytochrome P-450 4A mRNA and protein are also expressed in the glomerulus (20), there is no evidence that 20-HETE can be produced by this tissue. Indeed, all previous studies have reported that isolated glomeruli produce primarily cyclooxygenase and lipoxygenase metabolites when incubated with AA (5, 17, 21, 35). The results of the present study indicate that glomeruli can produce 20-HETE and diHETEs when incubated with AA in the presence of NAPDH at a PO2 typically found in the renal cortex of the rat (75-100 Torr). No cytochrome P-450 metabolites of AA were formed when NADPH was not added to the incubations. The formation of 20-HETE is also markedly reduced when the glomeruli are incubated in medium equilibrated with room air. These observations suggest that the inability to detect the formation of 20-HETE by glomeruli in previous studies was likely because NADPH was not added to the incubations and physiological PO2 levels for glomeruli were not maintained.
Why exogenous NADPH is required to exhibit cytochrome P-450 activity in glomeruli is unknown. We originally thought that the glomeruli were losing NADPH because they were permeablized with Tween 80. However, untreated glomeruli also required NADPH to form P-450 metabolites of AA. Addition of NADPH also enhances the formation of 20-HETE by isolated proximal tubules and renal arterioles, but unlike glomeruli, it is not required. NADPH is an essential cofactor for all cytochrome P-450 reactions. It is generated via the pentose shunt pathway and the citric acid cycle. It is possible that glomeruli lack the enzymatic machinery necessary to maintain adequate intracellular stores of NAPDH when incubated in vitro with glucose as the sole metabolic substrate. Exogenous NADPH may be taken up and replete intracellular stores in isolated glomeruli, or it may prevent the loss of NADPH by limiting diffusion. Regardless of how NADPH enhances the formation of P-450 metabolites of AA, our results suggest that addition of NADPH to the bath and maintaining physiological PO2 levels are important in the study of the contribution of P-450 metabolites of AA to mediation of renal tubular and vascular responses in vitro.
Because cytochrome P-450 4A activity
is high in the proximal tubules (29), we were concerned that the
production of 20-HETE observed in isolated glomeruli was an artifact
due to contamination of the preparations with adherent tubules.
However, this possibility seems remote, because alkaline phosphatase
activity (a marker for proximal tubules) was 20-fold greater in our
proximal tubular than in our glomerular preparations, but the
production of 20-HETE by proximal tubules was only twofold higher (8.58 ± 0.73 pmol · min
1 · mg
protein
1,
n = 6). Thus it seems unlikely that
the production of 20-HETE by isolated glomeruli can be explained solely
by the synthesis of this compound by adherent proximal tubules.
Moreover, we found that the levels of
-glutamyltransferase, a more
specific marker for proximal tubules (15), were 60-fold greater in our
proximal tubular than in our glomerular preparations. These
observations further support the conclusion that there was very little
contamination of our glomerular preparations.
The results of the present study indicating that glomeruli can avidly
produce 20-HETE contrast with the original findings of Omata et al.
(29). They reported that the
-hydroxylase activity of the kidney of
rats was primarily localized in proximal tubules. No significant
activity could be detected in glomeruli. However, the microdissected
nephron segments in that study were homogenized by freezing and
thawing, which diminish the activity of
P-450 enzymes. In addition, the
samples were not incubated in an
O2-rich environment. Under these
conditions, Omata et al. may have still been able to detect residual
activity in proximal tubules, but not in glomerular samples, in which
basal P-450 activity is lower.
The present study also explored the possibility that NO modulates the production of P-450 metabolites of AA in the glomerulus, as has been reported in renal microsomes and arterioles (1, 40). This hypothesis is based on the observations that NO inhibits NO synthase (1, 14, 15, 18) and P-450 enzymes of the 1A, 2B (46), 3C (22), and 4A (40) families by forming iron-nitrosyl complexes at the catalytic heme-binding site in these enzymes. The present results indicate that NO also inhibits the formation of 20-HETE in glomeruli in a concentration-dependent manner. However, our finding that glomeruli incubated without NO synthase inhibitors still produce 20-HETE indicates that the inactivation of glomerular P-450 enzymes by endogenously produced NO is not the reason why previous investigators failed to detect formation of P-450 metabolites of AA by isolated glomeruli.
Numerous studies have indicated that NO plays an important role in the regulation of glomerular hemodynamics. Blockade of NO synthesis increases arterial pressure, decreases renal blood flow and glomerular filtration rate, and potentiates tubuloglomerular feedback responses (26, 27, 41, 45). An endothelial form of NO synthase is highly expressed in the glomerulus (42). NO modulates the contractility of the mesangial cells, which regulates glomerular filtration by altering glomerular capillary surface area (25). The results of the present study suggest that NO may modify glomerular hemodynamics, in part by inhibiting the formation of 20-HETE. Our recent finding that preventing the fall in 20-HETE levels attenuates the renal vasodilator effect of NO (1, 40) is consistent with this hypothesis.
Besides playing an important role in regulation of renal vascular tone, there is evidence that NO modulates tubuloglomerular feedback responses. A neuronal isoform of NO synthase is expressed in the macula densa (26). Addition of inhibitors of NO synthase to tubular fluid enhances tubuloglomerular feedback responses, whereas addition of L-arginine to enhance the local formation of NO has the opposite effect (41, 45). We previously reported that 20-HETE plays a critical role as a mediator or a second messenger of tubuloglomerular feedback (48). Thus it is likely that NO may modulate the sensitivity of tubuloglomerular feedback by interfering with the formation of 20-HETE in the macula densa, the glomerulus, and/or the afferent arteriole.
The present study also examined the effects of changes in dietary salt intake on the production of 20-HETE and the levels of P-450 4A protein in the glomerulus. The production of 20-HETE was twofold greater and the expression of P-450 4A protein was sixfold greater in glomeruli isolated from rats fed a low-salt diet than in glomeruli isolated from rats fed a high-salt diet. It is unknown why there is not a better correlation between the changes in protein levels and enzyme activity. It may be that the difference in enzyme activity between the groups was underestimated, since the production of 20-HETE is substrate rather than enzyme limited and intracellular concentration of AA cannot be precisely controlled in incubations in which intact glomeruli are used. Alternatively, it is possible that some of the P-450 4A protein expressed in rats on a low-salt diet is inactive. It could be poisoned by endogenously produced NO or CO or lack association with the essential cofactors, heme and NADPH reductase.
Overall, the present results are consistent with other findings that the production of 20-HETE is greater in microsomes prepared from the kidneys of spontaneously hypertensive, Brown-Norway, Dahl salt-sensitive, and Dahl salt-resistant rats fed a low-salt diet than of those fed a high-salt diet (24, 29, 36, 38). More recently, we found that the expression of P-450 4A proteins in the liver, kidney, and renal microvessels is downregulated in rats fed a high-salt diet and that this can be prevented if circulating ANG II is maintained at normal levels by intravenous infusion (2). These observations suggest that P-450 4A activity is regulated by circulating ANG II levels and that changes in glomerular P-450 4A activity may contribute to the downregulation of tubuloglomerular feedback and renal vascular reactivity associated with the adaptation to a high-salt diet and the upregulation of these responses after activation of the renin-angiotensin system.
The results of the present study also indicate that isolated glomeruli exhibit epoxygenase activity and avidly produce EETs and diHETEs when incubated with AA. The formation of these products is also dependent on the addition of exogenous NAPDH and blocked by miconazole, indicating that the formation of these metabolites is catalyzed by a cytochrome P-450 enzyme. The production of diHETEs was greater in glomeruli isolated from the kidneys of Lewis rats fed a low-salt diet than in those fed a high-salt diet. This observation is consistent with previous reports that renal epoxygenase activity is higher in Dahl salt-sensitive (24, 36) and Brown-Norway rats (38) fed a low-salt diet than in those fed a high-salt diet. On the other hand, changes in salt intake had no effect on renal epoxygenase activity in Dahl salt-resistant or spontaneously hypertensive rats (24, 38). Moreover, Capdevila et al. (9) reported that renal epoxygenase activity increases in Sprague-Dawley rats fed a high-salt diet. This led them to propose that a failure to induce renal epoxygenase activity may contribute to the development of some forms of salt-induced hypertension. The reasons for the lack of consistent results concerning the effects of salt on renal epoxygenase activity are unknown. There are many P-450 isoforms (1A, 2C, 2J, 2E, and 4A), expressed in the kidney, that produce EETs (28). However, little is known about which of these isoforms are expressed in the glomerulus.
The present study also addressed the influence of changes in salt intake on glomerular 12-HETE production. Previous studies have indicated that 12-HETE and 15-hydroxyeicosatetraenoic acid are potent inhibitors of renin secretion (4). There is also considerable evidence indicating that feedback inhibition of renin secretion by ANG II is mediated by increased formation of 12-HETE in the kidney (3, 39). The present finding that the production of 12-HETE increases in glomeruli isolated from rats fed a high-salt diet is consistent with a recent finding of Stern et al. (39) that 12-HETE levels are elevated in renal cortical tissue of rats fed a high-salt diet. This finding is also supported by the view that increases in the formation of 12-HETE contribute to the fall in renin secretion in rats fed a high-salt diet (39).
Perspectives
The present results indicate that 1) the glomerulus produces 20-HETE, diHETEs, and 12-HETE when incubated with AA, 2) the formation of P-450 metabolites of AA by the glomerulus is dependent on NADPH and PO2, and 3) glomerular P-450 activity is modulated by NO and dietary salt intake. These results suggest that changes in the local production 20-HETE may influence glomerular hemodynamics and contribute to the modulation of glomerular function, renal vascular tone, and tubuloglomerular feedback responses produced by NO and changes in dietary salt intake. Given the importance of metabolites of AA in the regulation of glomerular hemodynamics and in mediating glomerular injury in hypertension, diabetes, and other disease states, our findings suggest that P-450 inhibitors and receptor antagonists might offer a new therapeutic approach to limit glomerular injury in a variety of disease states.| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Lisa Henderson for excellent technical assistance with the P-450 assays.
| |
FOOTNOTES |
|---|
This work was supported in part by National Heart, Lung, and Blood Institute Grants HL-29587 and HL-36279.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: R. J. Roman, Dept. of Physiology, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226 (E-mail: rroman{at}post.its.mcw.edu).
Received 25 August 1998; accepted in final form 9 February 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Alonso-Galicia, M.,
H. A. Drummond,
K. K. Reddy,
J. R. Falck,
and
R. J. Roman.
Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide.
Hypertension
29:
320-325,
1997
2.
Alonso-Galicia, M.,
A. S. Greene,
T. M. Kurth,
A. W. Cowley, Jr.,
and
R. J. Roman.
20-HETE contributes to the renal vasoconstrictor actions of angiotensin II (Abstract).
FASEB J.
13:
A389,
1999.
3.
Antonipillai, I.,
J. Nadler,
and
R. Horton.
Angiotensin feedback inhibition on renin is expressed via the lipoxygenase pathway.
Endocrinology
122:
1277-1281,
1988[Abstract].
4.
Antonipillai, I.,
J. L. Nadler,
E. C. Robin,
and
R. Horton.
The inhibitory role of 12- and 15-lipoxygenase products on renin release.
Hypertension
10:
61-66,
1987
5.
Ardaillou, R.,
L. Baud,
and
J. Sraer.
Leukotrienes and other lipoxygenase products of arachidonic acid synthesized in the kidney.
Am. J. Med.
81, Suppl. 2B:
12-22,
1986[Medline].
6.
Bowers, G. N.,
and
R. B. McComb.
A continuous spectrophotometric method for measuring the activity of serum alkaline phosphatase.
Clin. Chem.
12:
70-89,
1966[Abstract].
7.
Bradford, M. M.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:
248-254,
1976[Medline].
8.
Capdevila, J.,
L. Gil,
M. Orellanan,
N. J. Marnett,
J. I. Mason,
P. Yadagiri,
and
J. R. Falck.
Inhibitors of cytochrome P-450 dependent arachidonic acid metabolism.
Arch. Biochem. Biophys.
261:
257-263,
1988[Medline].
9.
Capdevila, J. H.,
W. Shouzou,
J. Yan,
A. Karara,
H. R. Jacobson,
J. R. Falck,
F. P. Guengerich,
and
R. N. DuBois.
Cytochrome P-450 arachidonic acid epoxygenase: regulatory control of the renal epoxygenase by dietary salt loading.
J. Biol. Chem.
267:
21720-21726,
1992
10.
Carroll, M. A.,
A. Sala,
C. E. Dunn,
J. C. McGiff,
and
R. C. Murphy.
Structural identification of cytochrome P-450-dependent arachidonate metabolites formed by rabbit medullary thick ascending limb cells.
J. Biol. Chem.
266:
12306-12312,
1992
11.
Escalante, B.,
D. Erlij,
J. R. Falck,
and
J. C. McGiff.
Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle.
Science
251:
799-802,
1991
12.
Escalante, B.,
W. C. Sessa,
J. R. Falck,
P. Yuclagiri,
and
M. L. Schwartzman.
Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase.
J. Pharmacol. Exp. Ther.
248:
229-232,
1989
13.
Gesek, F. A.,
D. W. Wolff,
and
J. W. Standhoy.
Improved separation for rat proximal and distal tubules.
Am. J. Physiol.
253 (Renal Fluid Electrolyte Physiol. 22):
F359-F365,
1987.
14.
Griscavage, J. M.,
A. J. Habbs,
and
L. J. Ignarro.
Negative modulation of nitric oxide synthase by nitric oxide and nitroso compounds.
Adv. Pharmacol.
34:
215-234,
1995.
15.
Hanigan, M. H.,
and
H. F. Frierson, Jr.
Immunohistochemical detection of
-glutamyl transpeptidase in normal human tissue.
J. Histochem. Cytochem.
44:
1101-1108,
1996[Abstract].
16.
Harder, D. R.,
J. Narayanan,
E. K. Birks,
J. F. Liard,
J. D. Imig,
J. H. Lombard,
A. R. Lange,
and
R. J. Roman.
Identification of a putative microvascular oxygen sensor.
Circ. Res.
79:
54-61,
1996
17.
Hassid, A.,
M. Konieczkowski,
and
M. J. Dunn.
Prostaglandin synthesis in isolated rat kidney glomeruli.
Proc. Natl. Acad. Sci. USA
76:
1155-1159,
1979
18.
Hurshman, A. R.,
and
M. A. Marletta.
Nitric oxide complexes of inducible nitric oxide synthase: spectral characterization and effects on catalytic activity.
Biochemistry
34:
5627-5634,
1995[Medline].
19.
Imig, J. D.,
A.-P. Zou,
D. E. Stec,
D. R. Harder,
J. R. Falck,
and
R. J. Roman.
Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles.
Am. J. Physiol.
270 (Regulatory Integrative Comp. Physiol. 39):
R217-R227,
1996
20.
Ito, O.,
M. Alonso-Galicia,
K. Hopp,
and
R. J. Roman.
Localization of cytochrome P-450 4A isoforms along the rat nephron segments.
Am. J. Physiol.
274 (Renal Physiol. 43):
F395-F404,
1998
21.
Katoh, T.,
K. Takahashi,
J. Capdevila,
A. Karara,
J. R. Falck,
H. R. Jacobson,
and
K. F. Badr.
Glomerular stereospecific synthesis and hemodynamic actions of 8,9-epoxyeicosatrienoic acid in rat kidney.
Am. J. Physiol.
261 (Renal Fluid Electrolyte Physiol. 30):
F578-F586,
1991
22.
Khatsenko, O. G.,
S. S. Gross,
A. B. Rifkind,
and
J. R. Vane.
Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants.
Proc. Natl. Acad. Sci. USA
90:
11147-11151,
1993
23.
Ma, Y.-H.,
D. Gebremedhin,
M. L. Schwartzman,
J. R. Falck,
J. E. Clark,
B. S. S. Masters,
D. R. Harder,
and
R. J. Roman.
20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries.
Circ. Res.
72:
126-136,
1993
24.
Ma, Y.-H.,
M. L. Schwartzman,
and
R. J. Roman.
Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats.
Am. J. Physiol.
267 (Regulatory Integrative Comp. Physiol. 36):
R579-R589,
1994
25.
Marsden, P. A.,
T. A. Brock,
and
B. J. Ballermann.
Glomerular endothelial cells respond to calcium-mobilizing agonists with release of EDRF.
Am. J. Physiol.
258 (Renal Fluid Electrolyte Physiol. 27):
F1295-F1303,
1990
26.
Mundel, P.,
S. Bachmann,
M. Bader,
A. Fischer,
W. Kummer,
B. Mayer,
and
W. Kriz.
Expression of nitric oxide synthase in kidney macula densa cells.
Kidney Int.
42:
1017-1019,
1992[Medline].
27.
Navar, L. G.,
E. W. Inscho,
D. S. A. Majid,
J. D. Imig,
L. M. Harrison-Bernard,
and
K. M. Mitchell.
Paracrine regulation of the renal microcirculation.
Physiol. Rev.
76:
425-536,
1996
28.
Nelson, D. R.,
T. Kamataki,
D. J. Waxman,
F. P. Guengerich,
R. W. Estabrook,
R. Feyereisen,
F. J. Gonzalez,
M. J. Coon,
I. C. Gunsalus,
O. Gotoh,
K. Okuda,
and
D. W. Nebert.
The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial name of enzymes, and nomenclature.
DNA Cell Biol.
12:
1-51,
1993[Medline].
29.
Omata, K.,
N. G. Abraham,
and
M. L. Schwartzman.
Renal cytochrome P-450-arachidonic acid metabolism: localization and hormonal regulation in SHR.
Am. J. Physiol.
262 (Renal Fluid Electrolyte Physiol. 31):
F591-F599,
1992
30.
Pedrosa Ribeiro, C. M.,
G. R. Dubay,
J. R. Falck,
and
L. J. Mandel.
Parathyroid hormone inhibits Na+-K+-ATPase through a cytochrome P-450 pathway.
Am. J. Physiol.
266 (Renal Fluid Electrolyte Physiol. 35):
F497-F505,
1994
31.
Sacerdoti, D.,
N. G. Abraham,
J. C. McGiff,
R. D. Levere,
and
M. L. Schwartzman.
Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats.
Science
243:
388-390,
1989
32.
Schwartzman, M. L.,
P. Martsek,
A. R. Rios,
R. D. Levere,
K. Solangi,
A. I. Goodman,
and
N. G. Abraham.
Cytochrome P450-dependent arachidonic acid metabolism in human kidney.
Kidney Int.
37:
94-99,
1990[Medline].
33.
Sekiya, K.,
and
H. Okuda.
Selective inhibition of platelet lipoxygenase by baicalein.
Biochem. Biophys. Res. Commun.
105:
1090-1095,
1982[Medline].
34.
Spiro, R. G.
Studies on the renal glomerular basement membrane.
J. Biol. Chem.
242:
1915-1922,
1967
35.
Sraer, J.,
M. Rigarud,
M. Bens,
H. Radinovitch,
and
R. Ardaillou.
Metabolism of arachidonic acid via the lipoxygenase pathway in human and murine glomeruli.
J. Biol. Chem.
258:
4325-4330,
1983
36.
Stec, D. E.,
A. Y. Deng,
J. P. Rapp,
and
R. J. Roman.
Cytochrome P450 4A genotype cosegregates with hypertension in Dahl S rats.
Hypertension
27:
564-568,
1996
37.
Stec, D. E.,
D. L. Mattson,
and
R. J. Roman.
Inhibition of renal outer medullary 20-HETE production produces hypertension in Lewis rats.
Hypertension
29:
315-319,
1997
38.
Stec, D. E.,
M. R. Trolliet,
J. E. Krieger,
H. J. Jacob,
and
R. J. Roman.
Renal cytochrome P450 4A activity and salt sensitivity in spontaneously hypertensive rats.
Hypertension
27:
1329-1336,
1996
39.
Stern, N.,
K. Nozawa,
E. Kisch,
M. L. Tuck,
M. Golub,
P. Eggena,
and
E. Knoll.
Tonic inhibition of renin secretion by the 12-lipoxygenase pathway: augmentation by high salt intake.
Endocrinology
137:
1878-1884,
1996[Abstract].
40.
Sun, C. W.,
M. Alonso-Galicia,
R. M. Taheri,
J. R. Falck,
D. R. Harder,
and
R. J. Roman.
Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles.
Circ. Res.
83:
1-11,
1998
41.
Thorup, C.,
and
A. E. G. Persson.
Macula densa derived nitric oxide in regulation of glomerular capillary pressure.
Kidney Int.
49:
430-436,
1996[Medline].
42.
Ujiie, K.,
J. Yuen,
L. Hogarth,
R. Danziger,
and
R. A. Star.
Localization and regulation of endothelial NO synthase mRNA expression in rat kidney.
Am. J. Physiol.
267 (Renal Fluid Electrolyte Physiol. 36):
F296-F302,
1994
43.
Wang, M.-H.,
D. E. Stec,
M. Balazy,
V. Mastyugin,
C. S. Yang,
R. J. Roman,
and
M. L. Schwartzman.
Cloning, sequencing, and cDNA-directed expression of the rat renal CYP 4A2: arachidonic acid
-hydroxylation and 11,12-epoxidation by CYP 4A2 protein.
Arch. Biochem. Biophys.
336:
240-250,
1996[Medline].
44.
Wang, W. H.,
and
H. Lu.
Effect of arachidonic acid on activity of the apical K channel in the thick ascending limb of the rat kidney.
J. Gen. Physiol.
106:
727-743,
1995
45.
Wilcox, C. S.,
W. J. Welch,
F. Murad,
S. S. Gross,
G. Taylor,
R. Levi,
and
H. H. Schmidt.
Nitric oxide synthase in macula densa regulates glomerular capillary pressure.
Proc. Natl. Acad. Sci. USA
89:
11993-11997,
1992
46.
Wink, D. A.,
Y. Osawa,
J. F. Darbyshine,
C. R. Jones,
S. C. Eshenaus,
and
R. W. Nims.
Inhibition of cytochrome P450 by nitric oxide and a nitric oxide releasing agent.
Arch. Biochem. Biophys.
300:
115-123,
1993[Medline].
47.
Zou, A.-P.,
J. D. Imig,
M. Kaldunski,
P. R. Ortiz de Montellano,
Z.-H. Sui,
and
R. J. Roman.
Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow.
Am. J. Physiol.
266 (Renal Fluid Electrolyte Physiol. 35):
F275-F282,
1994
48.
Zou, A.-P.,
J. D. Imig,
P. R. Ortiz de Montellano,
Z.-H. Sui,
J. R. Falck,
and
R. J. Roman.
Effect of P-450
-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback.
Am. J. Physiol.
266 (Renal Fluid Electrolyte Physiol. 35):
F934-F941,
1994
49.
Zou, A.-P.,
Y.-H. Ma,
Z.-H. Sui,
P. R. Ortiz de Montellano,
J. E. Clark,
B. S. Masters,
and
R. J. Roman.
Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome 450 fatty acid
-hydroxylase, on renal function in rat.
J. Pharmacol. Exp. Ther.
268:
474-481,
1993
This article has been cited by other articles:
![]() |
V. Nilakantan, C. Maenpaa, G. Jia, R. J. Roman, and F. Park 20-HETE-mediated cytotoxicity and apoptosis in ischemic kidney epithelial cells Am J Physiol Renal Physiol, March 1, 2008; 294(3): F562 - F570. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Williams, M. Sharma, S. Anjaiahh, J. R. Falck, and R. J. Roman Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier Am J Physiol Renal Physiol, August 1, 2007; 293(2): F501 - F505. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Yiu, X. Zhao, E. W. Inscho, and J. D. Imig 12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels J. Lipid Res., December 1, 2003; 44(12): 2391 - 2399. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Hoagland, A. K. Flasch, and R. J. Roman Inhibitors of 20-HETE Formation Promote Salt-Sensitive Hypertension in Rats Hypertension, October 1, 2003; 42(4): 669 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yu, R. P. McAndrew, R. Al-Saghir, K. G. Maier, M. Medhora, R. J. Roman, and E. R. Jacobs Nitric oxide contributes to 20-HETE-induced relaxation of pulmonary arteries J Appl Physiol, October 1, 2002; 93(4): 1391 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ito, K. Omata, S. Ito, K. M. Hoagland, and R. J. Roman Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R822 - R830. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Imig Eicosanoid regulation of the renal vasculature Am J Physiol Renal Physiol, December 1, 2000; 279(6): F965 - F981. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Quigley, M. Baum, K. M. Reddy, J. C. Griener, and J. R. Falck Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport Am J Physiol Renal Physiol, June 1, 2000; 278(6): F949 - F953. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||